Lineage Cell Therapeutics, Inc. Increase (Decrease) in Inventories
Lineage Cell Therapeutics, Inc. (LCTX) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2017-03-16
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2016-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2016-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for fiscal 2015 was $75.00K, a 13.79% decline from fiscal 2014.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for fiscal 2014 was $87.00K, a 29.27% decline from fiscal 2013.
- Lineage Cell Therapeutics, Inc. increase (decrease) in inventories for fiscal 2013 was $123.00K, a 2870.30% increase from fiscal 2012.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $0.00 10-Q · filed 2016-11-04 | $81.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $81.00K derived: sum of 3 quarters · filed 2017-03-16 | $45.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | $81.00K derived: sum of 2 quarters · filed 2017-03-16 | $45.00K derived: sum of 3 quarters · filed 2017-03-16 | $42.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $45.00K derived: sum of 2 quarters · filed 2017-03-16 | $42.00K derived: sum of 3 quarters · filed 2017-03-16 | $75.00K 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | -$39.00K derived: sum of 2 quarters · filed 2016-11-04 | -$6.00K 10-Q · filed 2016-11-04 | $6.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $30.00K 10-Q · filed 2016-08-09 | $42.00K derived: sum of 3 quarters · filed 2017-03-16 | $38.00K derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $33.00K 10-Q · filed 2016-05-10 | $33.29K 10-Q · filed 2015-05-08 | $45.00K derived: sum of 2 quarters · filed 2017-03-16 | $41.00K derived: sum of 3 quarters · filed 2017-03-16 | $62.11K derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $8.00K derived: sum of 2 quarters · filed 2017-03-16 | $29.11K derived: sum of 3 quarters · filed 2017-03-16 | $87.00K 10-K · filed 2017-03-16 | $87.33K 10-K · filed 2015-03-11 | |||
| 2014-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $17.11K derived: sum of 2 quarters · filed 2015-11-09 | $75.00K 10-Q · filed 2015-11-09 | $74.87K 10-Q · filed 2014-11-07 | $192.18K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $21.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $79.00K 10-Q · filed 2015-08-10 | $79.24K 10-Q · filed 2014-08-11 | $196.18K derived: sum of 3 quarters · filed 2016-03-15 | $192.57K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $57.89K 10-Q · filed 2015-05-08 | $175.08K derived: sum of 2 quarters · filed 2016-03-15 | $171.47K derived: sum of 3 quarters · filed 2016-03-15 | $183.88K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $117.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $113.57K derived: sum of 2 quarters · filed 2016-03-15 | $125.98K derived: sum of 3 quarters · filed 2016-03-15 | $123.00K 10-K · filed 2016-03-15 | $123.38K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | -$3.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $8.80K derived: sum of 2 quarters · filed 2014-11-07 | $5.82K 10-Q · filed 2014-11-07 | $4.16K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $12.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $9.43K 10-Q · filed 2014-08-11 | $7.78K derived: sum of 3 quarters · filed 2015-03-11 | $9.73K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | -$2.98K 10-Q · filed 2014-05-12 | -$4.63K derived: sum of 2 quarters · filed 2015-03-11 | -$2.68K derived: sum of 3 quarters · filed 2015-03-11 | -$2.53K derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | -$1.65K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $297.00 derived: sum of 2 quarters · filed 2015-03-11 | $449.00 derived: sum of 3 quarters · filed 2015-03-11 | $4.14K 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $1.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $2.10K derived: sum of 2 quarters · filed 2013-11-12 | $5.79K 10-Q · filed 2013-11-12 | -$4.15K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $152.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.84K 10-Q · filed 2013-08-09 | -$6.10K derived: sum of 3 quarters · filed 2014-03-17 | -$1.82K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $3.69K 10-Q · filed 2013-05-10 | -$6.25K derived: sum of 2 quarters · filed 2014-03-17 | -$1.98K derived: sum of 3 quarters · filed 2014-03-17 | -$18.29K derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | -$9.94K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$5.67K derived: sum of 2 quarters · filed 2014-03-17 | -$21.98K derived: sum of 3 quarters · filed 2014-03-17 | -$31.09K 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $4.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$12.04K derived: sum of 2 quarters · filed 2012-11-09 | -$21.15K 10-Q · filed 2012-11-09 | $21.15K 10-Q · filed 2011-11-08 | $1.03K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-06-30 | -$16.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$25.43K 10-Q · filed 2012-08-09 | $25.43K 10-Q · filed 2011-08-09 | -$3.24K derived: sum of 3 quarters · filed 2013-03-18 | -$3.24K derived: sum of 4 quarters · filed 2013-03-18 | |||
| 2011-03-31 | -$9.11K 10-Q · filed 2012-05-10 | $13.08K derived: sum of 2 quarters · filed 2013-03-18 | $13.08K derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $22.19K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $22.19K derived: sum of 2 quarters · filed 2013-03-18 | $11.09K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$11.09K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | -$11.09K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $38.38K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |